CareDx (CDNA) Tops Q4 EPS by 11c

CareDx (NASDAQ: CDNA) reported Q4 EPS of $0.00, $0.11 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $7.96 million versus the consensus estimate of $6.86 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• Sanuwave Q2 2026 revenue tops revised guidance range
• JD.com, Inc (JD) PT Lowered to $37 at Macquarie ahead of earnings